Reality TV supernova Kim Kardashian being paid to tout a prescription drug on social media—what could go wrong?
The pregnant wife of rapper Kanye West recently turned to Instagram, Facebook and Twitter to post a breathless rave about Diclegis, a morning sickness drug manufactured by Duchesnay. Kardashian's pitch began, “OMG, have you heard about this?”
But the Food and Drug Administration frowned on the posts, saying they violated federal drug advertising rules because they promoted the product's efficacy without including any information about its side effects or limitations of its use.
“These violations are concerning from a public health perspective because they suggest that Diclegis is safer than has been demonstrated,” the agency said in an Aug. 7 letter to Duchesnay, which has since worked with Kardashian to remove the posts.
Outliers feels compelled to note this may be the first time the FDA, in quoting her post, has used “OMG” (short for “oh my god,” for those not conversant in texting abbreviations) in its formal correspondence.
The agency told Duchesnay it must immediately cease misbranding the drug and respond with a plan to prevent future marketing issues. Duchesnay said in a statement that it “will take quick action in responding to the FDA's letter and immediately and effectively address any issues.”
Earlier endorsement deals by Kardashian—who is reported to be paid up to $1 million for backing a product—have decidedly been outside the FDA's realm, and have included lollipops, gym shoes, costume jewelry, makeup, Midori liqueur and a Sears clothing line.
